Literature DB >> 9646105

Antibody testing and RT-PCR results in hepatitis C virus (HCV) infection: HCV-RNA detection in PBMC of plasma viremia-negative HCV-seropositive persons.

C Caudai1, M G Padula, I Bastianoni, P E Valensin, V Shyamala, J Han, C A Boggiano, P Almi.   

Abstract

To evaluate the concordance between viremia and antibody testing in hepatitis C virus (HCV) diagnosis, 682 serum or plasma samples collected from patients with known or suspected HCV infection were tested. An overall concordance of 77% between serological and PCR results was found, 5% was RNA positive/antibody negative and 18% antibody positive/RNA negative. The relationship between HCV infection, risk group and clinical diagnosis was studied in 116 patients: the presence of anti-HCV antibody without viremia was shown in 72.7% of asymptomatic subjects and 17.6% of chronic hepatitis subjects without interferon treatment. However, the detection of HCV-RNA in peripheral blood mononuclear cells (PBMC) in four out of 38 plasma viremia-negative HCV-seropositive subjects (10.5%), showed that HCV-RNA could persist in PBMC and could begin the viral replication again at different times. The detection of HCV-RNA in PBMC in anti-HCV-positive subjects without viremia could reduce false-negative results of HCV-RNA testing by RT-PCR in serum or plasma.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9646105     DOI: 10.1007/bf02771840

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  23 in total

1.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

Authors:  Q L Choo; G Kuo; A J Weiner; L R Overby; D W Bradley; M Houghton
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

2.  Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection.

Authors:  M J Alter; S C Hadler; F N Judson; A Mares; W J Alexander; P Y Hu; J K Miller; L A Moyer; H A Fields; D W Bradley
Journal:  JAMA       Date:  1990-11-07       Impact factor: 56.272

3.  Detection of HCV and GBV-C/HGV infection by multiplex PCR in plasma samples of transfused subjects.

Authors:  C Caudai; M G Padula; V Bettini; P E Valensin
Journal:  J Virol Methods       Date:  1998-01       Impact factor: 2.014

4.  Infection of peripheral mononuclear blood cells by hepatitis C virus.

Authors:  A L Zignego; D Macchia; M Monti; V Thiers; M Mazzetti; M Foschi; E Maggi; S Romagnani; P Gentilini; C Bréchot
Journal:  J Hepatol       Date:  1992-07       Impact factor: 25.083

Review 5.  Polymerase chain reaction for the diagnosis of viral hepatitis B and C.

Authors:  C Bréchot
Journal:  Gut       Date:  1993       Impact factor: 23.059

6.  Presence of viral replicative intermediates in the liver and serum of patients infected with hepatitis C virus.

Authors:  A H Sherker; J S Twu; G R Reyes; W S Robinson
Journal:  J Med Virol       Date:  1993-02       Impact factor: 2.327

7.  Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay.

Authors:  J Bukh; R H Purcell; R H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

8.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.

Authors:  G Kuo; Q L Choo; H J Alter; G L Gitnick; A G Redeker; R H Purcell; T Miyamura; J L Dienstag; M J Alter; C E Stevens
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

Review 9.  Hepatitis C: progress and problems.

Authors:  J A Cuthbert
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

10.  Significance of highly positive c22-3 "indeterminate" second-generation hepatitis C virus (HCV) recombinant immunoblot assay (RIBA) and resolution by third-generation HCV RIBA.

Authors:  J M Pawlotsky; A Fleury; V Choukroun; L Deforges; F Roudot-Thoraval; P Aumont; J Duval; D Dhumeaux
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

View more
  6 in total

1.  Variable expressions of Staphylococcus aureus bicomponent leucotoxins semiquantified by competitive reverse transcription-PCR.

Authors:  S Bronner; P Stoessel; A Gravet; H Monteil; G Prévost
Journal:  Appl Environ Microbiol       Date:  2000-09       Impact factor: 4.792

2.  Ten year incidence of HCV infection in northern Italy and frequency of spontaneous viral clearance.

Authors:  C Mazzeo; F Azzaroli; S Giovanelli; A Dormi; D Festi; A Colecchia; A Miracolo; P Natale; G Nigro; A Alberti; E Roda; G Mazzella
Journal:  Gut       Date:  2003-07       Impact factor: 23.059

3.  Vertical transmission of the hepatitis C virus to infants of anti-human immunodeficiency virus-negative mothers: molecular evolution of hypervariable region 1 in prenatal and perinatal or postnatal infections.

Authors:  C Caudai; M Battiata; M P Riccardi; M Toti; P Bonazza; M G Padula; M Pianese; P E Valensin
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

4.  A retrospective analysis of treatment outcomes in patients with hepatitis C related systemic vasculitis receiving intravenous methylprednisolone and cyclophosphamide.

Authors:  Amira A Shahin; Soha M El Desouky; Hania S Zayed
Journal:  Clin Rheumatol       Date:  2010-10-06       Impact factor: 3.650

5.  Usefulness of a fourth generation ELISA assay for the reliable identification of HCV infection in HIV-positive adults from Gabon (Central Africa).

Authors:  François Rouet; Luc Deleplancque; Berthold Bivigou Mboumba; Jeanne Sica; Augustin Mouinga-Ondémé; Florian Liégeois; Alain Goudeau; Frédéric Dubois; Catherine Gaudy-Graffin
Journal:  PLoS One       Date:  2015-01-24       Impact factor: 3.240

Review 6.  Diagnostic accuracy of tests to detect Hepatitis C antibody: a meta-analysis and review of the literature.

Authors:  Weiming Tang; Wen Chen; Ali Amini; Debi Boeras; Jane Falconer; Helen Kelly; Rosanna Peeling; Olivia Varsaneux; Joseph D Tucker; Philippa Easterbrook
Journal:  BMC Infect Dis       Date:  2017-11-01       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.